CAM
FLGT icon

Cresset Asset Management’s Fulgent Genetics FLGT Stock Holding History

Cresset Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,174
Closed -$329K – 2124
2024
Q1 		$329K Sell
15,174
-39,072
-72% -$970K ﹤0.01% 1532
2023
Q4 		$1.57M Buy
54,246
+8,795
+19% +$235K 0.01% 688
2023
Q3 		$1.22M Buy
45,451
+4,403
+11% +$150K ﹤0.01% 757
2023
Q2 		$1.52M Buy
+41,048
New +$1.43M ﹤0.01% 749
2022
Q1 		– Sell
-6,325
Closed -$637K – 1045
2021
Q4 		$637K Buy
+6,325
New +$556K 0.01% 614

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cresset Asset Management's FLGT Position: Q2 2024 in Review

Cresset Asset Management sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 15,174 shares — an estimated $329K sold.

Cresset Asset Management first reported a position in FLGT in Q4 2021 and held it in 5 quarters. The position peaked at $1.57M in Q4 2023. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • Cresset Asset Management reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • Cresset Asset Management sold 15,174 Fulgent Genetics shares in Q2 2024, an estimated $329K.
  • Cresset Asset Management first reported a position in Fulgent Genetics in Q4 2021 and held it in 5 quarters.
  • Cresset Asset Management's Fulgent Genetics position peaked at $1.57M in Q4 2023.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on Cresset Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.